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was associated with greater odds of overall, medial, and nonsigniﬁcantly
with lateral hamstring co-activation compared with those in the highest
tertile (Table). Similar but mainly nonsigniﬁcant associations were noted
when limited to only those with radiographic knee OA. No associations
were noted for sensitization with the middle vs. lowest tertiles of muscle
co-activation.
Conclusions: In this initial evaluation, presence of sensitization as
assessed by temporal summation and lower PPT was generally associated
with greater hamstring co-activation during knee extension. This
provides support to the possibility that peripheral/central nervous
system alterations may not only affect pain sensitivity, but also motor
function.
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Purpose: The knowledge of the distribution and the modulation that
proteins suffer in the different phases of the rheumatic pathologies is
essential to understand the development of these diseases and to ﬁnd
the best targets for treatment. Imaging mass spectrometry (IMS) allows
us to study the spatial distribution of different components with a high
resolution, through a section of tissue. It permits also the identiﬁcation
of many proteins at the same time without labeling. In this study, we
have studied the localization of proteins associated with OA pathology in
different areas of normal and OA human cartilage by MALDI-imaging.
Methods: Human control and OA cartilage samples were cut in triplicate
obtaining 10mm thick sections and deposited on indium tin oxide
(ITO) high conductivity slides. For MALDI imaging experiments different
washing and enzymatic steps were performed. For imaging purposes
spots of trypsin were deposited by a high-accuracy position automatic
chemical inkjet printer. Alpha-Cyano-4-hydroxycinnamic acid matrix
(HCCA) was deposited by a vibrational sprayer system. A Synapt
HDMS MALDI-Q-TOF was used to perform the imaging-MS and MS/MS
experiments with a spatial resolution of 150mm. To perform the peptide
identiﬁcation, the Mascot algorithm was employed after proﬁling MS/MS
and imaging-MS/MS experiments. Biomap software was used to study
the localization and the intensity of the different peptides. Hematoxylin-
eosin staining was performed to complement the spatial information.
Principal component analysis (PCA) and discriminant analyses (DA) were
used for data interpretation.
Results: We have created speciﬁc peptide/protein maps in control and
OA cartilage slides identifying and localizing proteins by proﬁling MALDI-
MS/MS and imaging MS/MS experiments on tissue. For the ﬁrst time,
well known proteins such as Biglycan, Prolargin, Aggrecan core protein
or Decorin have been identiﬁed directly from the tissue with this
technique in the human control cartilage samples. In addition to this,
important OA biomarkers have been identiﬁed and localized. Different
peptides of Cartilage oligomeric matrix protein (COMP) (m/z 1613.83,
2256.15), Fibronectin (m/z 1349.72, 1401.71, 1591.87, 1913.03) or Cartilage
intermediate layer protein 1 (CILP1) (m/z 1954.00) were found in the OA
tissues. MS/MS experiments of digested peptides in solution conﬁrmed
these results. After normalizing the intensity of these peaks using the
Biomap software, we observed that the presence of these peptides was
higher in OA than in normal samples as we expected. Interestingly, their
distribution seemed to be more evident in the deep cartilage than in the
superﬁcial area. By means of PCA and DA analyses between control and
OA groups we created a list of peaks that differentiate OA samples. The
larger part of these OA-related peaks, were localized again in the deep
area.
Conclusions: We have localized and identiﬁed proteins in normal and
OA human cartilage by MALDI-imaging. Classical biomarkers of OA are
mostly distributed in the deep area. These results support that the cross-
talk between the cartilage and the bone could be relevant in the OA
development.
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HIGH ADAMTS4 OR 5 ACTIVITY AND SEVERE ARTICULAR CARTILAGE
AGGRECAN DEPLETION ONLY DO NOT LEAD TO OA IN YOUNG MICE
UNDER STANDARD LABORATORY CONDITIONS
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Background: Joint diseases such as osteoarthritis (OA) result in
destruction of articular cartilage and loss of joint function. The main
structural components of articular cartilage are, besides water, type II
collagen and aggrecan. Aggrecan is considered the molecule responsible
for the load-resistant characteristics of cartilage. The two main enzymes
that degrade aggrecan are identiﬁed as ADAMTS4 (aggrecanase-1) and
ADAMTS5 (aggrecanase-2).
Purpose: We studied whether local over-expression of human ADAMTS4
or 5, only in the knee joint, was possible and if this resulted in OA
development.
Methods: Two unique transgenic mouse strains (Balb/c background)
that express inducible active ADAMTS4 or ADAMTS5 were developed.
These strains contain ﬂoxed human ADAMTS4 or ADAMTS5 genes and
transcription is only activated after tamoxifen exposure. Transgenic mice
and control littermates were injected in the right knee joint with
4-hydroxytamoxifen (4-HOT), highest dose 5 microgram/joint. Whole
knee joints of mice sacriﬁced at 2 and 42 days after 4-HOT injection
were sectioned and stained.
Results: Intra-articular injection of 4-HOT in ADAMTS transgenic mice
resulted in expression of ADAMTS, solely in the injected knee joint.
Injection of 4-HOT in control littermates did not lead to any observable
effect. In ADAMTS mice, on day 2 after 4-HOT injection, the articular
cartilage showed clear aggrecan loss. Loss of aggrecan progressed over
time and after 42 days severe aggrecan depletion was present in
the femoral-tibial and patella-femoral cartilage. In aggrecan-depleted
cartilage, a few chondrocytes were surrounded by an intensely safranin
O-stained halo. Remarkably, apart from aggrecan depletion no other
indication of pathology, such as inﬂammation or tissue damage, was
observed. Neither human ADAMTS expression nor aggrecan loss was seen
in any other joints of the 4-HOT injected mice. To our great surprise, no
structural sign of OA, such as surface ﬁbrillation or erosions, were present
in the severely aggrecan-depleted cartilage at day 42, although aggrecan
depletion in the knee joints of these mice was severe for weeks.
Conclusion: ADAMTS4 or 5 can be locally over-expressed in the knee
joint of inducible transgenic mice. This leads to severe aggrecan depletion
but not to development of OA-like cartilage lesions within 6 weeks.
Merely elevated ADAMTS activity and loss of aggrecan is not sufﬁcient
to induce damage in young mice. Apparently, an additional trigger,
damaging the collagen matrix such as increased loading, is essential
to cause OA in aggrecan-depleted cartilage in young ADAMTS4 and
ADAMTS5 transgenic mice under standard laboratory conditions.
